Where Self Meets Gluten in the Birth of Transglutaminase Autoantibodies in Celiac Disease
; Anderson, Robert P. Otros responsables
Fecha
12/2025
Editorial
W B Saunders Co-Elsevier Inc
Revista
Gastroenterology
Título del libro
Nombre del evento
Fecha del evento
Institución organizadora
ISSN
0016-5085
eISSN
ISBN
Idioma
Inglés
Tipo del evento
Clasificación temática
Palabras clave
Resumen
C eliac disease (CeD) is an unfortunate and perhapsinevitable consequence of our reliance on wheat,rye, and barley to provide substantial sources of dietaryprotein and carbohydrate. Approximately 1% of populationsconsuming wheat, rye, and barley are affected byCeD.1 Despite growing public and medical awareness overthe last 2 decades, unrecognized, misdiagnosed, andpersistently active CeD continues to be a common publichealth issue.1The biology of transglutaminase 2 (TG2) has played anunexpected but profound role in understanding and managingCeD. TG2 expression is low in the healthy intestinalmucosa, but cytosolic TG2 is released during apoptosis andepithelial shedding, and its expression in the gut isenhanced by injury and innate immune stimuli.2 TG2 catalyzesthe release of ammonia (deamidation) from selectedglutamine residues in peptides and proteins, includinggluten. The product of this posttranslational modification isglutamate in acidic conditions, or in neutral and mildlyalkaline conditions, a covalent (isopeptide) bond is formedbetween glutamate and an amine donor.
Colecciones
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa
